• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WALLFLEX ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WALLFLEX ESOPHAGEAL; PROSTHESIS, ESOPHAGEAL Back to Search Results
Device Problem Obstruction of Flow (2423)
Patient Problem Dysphagia/ Odynophagia (1815)
Event Date 12/01/2021
Event Type  Injury  
Manufacturer Narrative
Date of event: approximated based on the date the manufacturer became aware of the event.The complainant was unable to provide the suspect device upn and lot number.Therefore, the manufacture and expiration dates are unknown.(b)(4).The complainant indicated that the stent remains implanted; therefore, a product analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.
 
Event Description
Note: this report pertains to one of two wallflex esophageal stents used in the same patient.Refer to manufacturer report # 3005099803-2021-07957 for the associated device information.It was reported to boston scientific corporation on (b)(6) 2021 that a wallflex esophageal stent was implanted to treat a malignant esophageal stricture during an endoscopy procedure performed on an unknown date.Reportedly, the patient's anatomy was not tight prior to stent placement.A few months after the first wallflex esophageal stent (the subject of this report) was implanted, the patient presented with dysphagia.Endoscopy was performed and ingrowth was noted.A stent-in-stent procedure was done using another wallflex esophageal stent (the subject of mfr.# 3005099803-2021-07957) to complete the procedure.Three weeks after the stent-in-stent procedure, the patient presented with dysphagia and ingrowth was again noted.Reportedly, ablation and a stent-in-stent procedure was done to complete the procedure.
 
Event Description
Note: this report pertains to one of two wallflex esophageal stents used in the same patient.Refer to manufacturer report 3005099803-2021-07957 for the associated device information.It was reported to boston scientific corporation on (b)(6) 2021 that a wallflex esophageal stent was implanted to treat a malignant esophageal stricture during an endoscopy procedure performed on an unknown date.Reportedly, the patient's anatomy was not tight prior to stent placement.A few months after the first wallflex esophageal stent (the subject of this report) was implanted, the patient presented with dysphagia.Endoscopy was performed and ingrowth was noted.A stent-in-stent procedure was done using another wallflex esophageal stent (the subject of mfr.# 3005099803-2021-07957) to complete the procedure.Three weeks after the stent in stent procedure, the patient presented with dysphagia and ingrowth was again noted.Reportedly, ablation and a stent-in-stent procedure was done to complete the procedure.Additional information received on december 21, 2021.It was reported that both stents were non-removable, partially covered wallflex esophageal stents.
 
Manufacturer Narrative
Blocks b3: approximated based on the date the manufacturer became aware of the event.Block d4, h4: the complainant was unable to provide the suspect device upn and lot number.Therefore, the manufacture and expiration dates are unknown.Block h6: medical device problem code a1409 captures the reportable event of stent ingrowth.Impact code f2301 captures the additional intervention of another stent placement.Conclusion code d17 is being used in lieu of an adequate conclusion code for device not returned.Block h10: the complainant indicated that the stent remains implanted; therefore, a product analysis of the complaint device could not be completed.If any further relevant information is identified, a supplemental medwatch will be filed.Block h11: block b5 has been corrected based on additional information received on december 21, 2021.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WALLFLEX ESOPHAGEAL
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key13094219
MDR Text Key282820248
Report Number3005099803-2021-07958
Device Sequence Number1
Product Code ESW
Combination Product (y/n)N
Reporter Country CodePO
PMA/PMN Number
K073266
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/02/2021
Initial Date FDA Received12/28/2021
Supplement Dates Manufacturer Received12/21/2021
Supplement Dates FDA Received01/14/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-